Back to top
more

Better trading starts here.

Brokerage Reports

Research for BPMC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

1 item in cart

View Cart/Checkout

Blueprint Medicines Corporation [BPMC]

Reports for Purchase

Showing records 1 - 20 ( 518 total )

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 1

07/08/2024

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 2

06/21/2024

Industry Report

Pages: 11

HEALTHCARE -The Week Ahead in Life Sciences

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 3

06/18/2024

Financial Spreadsheet

Pages: 3

Company Model

Provider: Zacks Investment Research

Analyst: CHAKRABORTY A

Price: .00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 4

06/18/2024

Company Report

Pages: 10

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 5

06/07/2024

Industry Report

Pages: 10

The Week Ahead in Life Sciences

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 6

06/03/2024

Industry Report

Pages: 36

Key Takeaways for ASCO 2024; Roundup for Covered Companies

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 75.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 7

05/24/2024

Industry Report

Pages: 25

Biotechnology -ASCO 2024 Abstract Roundup for Covered Companies

Provider: Wedbush Securities Inc.

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 8

05/14/2024

Financial Spreadsheet

Pages: 3

Company Model

Provider: Zacks Investment Research

Analyst: CHAKRABORTY A

Price: .00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 9

05/14/2024

Industry Report

Pages: 13

EHA 2024 Abstract Roundup for Covered Companies

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 10

05/14/2024

Company Report

Pages: 10

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 11

05/07/2024

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 12

05/03/2024

Company Report

Pages: 7

ISM Now Stands for ?Impactful Sales Momentum?; Reit. Buy and Increasing our PT to $135

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 25.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 13

05/02/2024

Company Report

Pages: 7

Ayvakit Surprises to the Upside with a Beat and Raise

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 14

04/26/2024

Daily Note

Pages: 16

MORNING CALL

Provider: Wedbush Securities Inc.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 15

04/26/2024

Daily Note

Pages: 4

BLU-808 Shapes A Pillar of Potential Upside For BPMC, Driven by Other Mast Cell Disorders

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 10.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 16

04/26/2024

Industry Report

Pages: 11

The Week Ahead in Life Sciences

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 17

04/25/2024

Industry Report

Pages: 9

Biotechnology- ASCO 2024 Abstract Titles for Covered Companies

Provider: Wedbush Securities Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 18

04/25/2024

Daily Note

Pages: 7

Mastering Mast Cells with BLU-808 in the Spotlight

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 19

04/25/2024

Industry Report

Pages: 9

ASCO 2024 Abstract Titles for Covered Companies

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: Blueprint Medicines Corporation

Industry: Medical - Biomedical and Genetics

Record: 20

04/19/2024

Industry Report

Pages: 12

The Week Ahead in Life Sciences

Provider: Wedbush Securities Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party